UQCRHP4

Across TCGA pan-cancer cohorts, UQCRHP4 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of UQCRHP4’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where UQCRHP4 RNA is repressed in tumor relative to normal tissue. In most cancer types UQCRHP4 is over-expressed in tumor, although a few such as THCA and BLCA show the opposite, repressed pattern.

THCA, BLCA, and LUAD are the cancer types where UQCRHP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UQCRHP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	All	−0.370	<.001	11	view →
BLCA	All	IV	−0.465	.023	3	view →
LUAD	All	All	+0.102	.008	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

UQCRHP4–THCA

Open the THCA breakdown →